<DOCUMENT>
<TYPE>10KSB
<SEQUENCE>1
<FILENAME>tomi_10ksb-123107.txt
<DESCRIPTION>FORM 10-KSB FOR THE FISCAL YEAR ENDED 12/31/07
<TEXT>


                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  FORM 10-KSB

[X]  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
     SECURITIES EXCHANGE ACT OF 1934

     For the fiscal year ended December 31, 2007

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
     SECURITIES AND EXCHANGE ACT OF 1934

                        Commission file number 000-09908

                               THE OZONE MAN, INC.
                 (Name of small business issuer in its charter)

             Florida                                59-1947988
     (State of incorporation)          (I.R.S. Employer Identification No.)

9454 Wilshire Blvd., Penthouse, Beverly Hills, CA                  90212
     (Address of principal executive offices)                    (Zip code)

                Issuer's telephone number, including area code:
                                 (800) 525-1698

Securities registered under Section 12(b) of the Exchange Act:  None

Securities registered under Section 12(g) of the Exchange Act:  Common Stock

Check whether the issuer is not required to file reports pursuant to Section 13
or 15(d) of the Exchange Act. [ ]

The issuer (1) filed all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the registrant was required to file such reports) and (2)
has been subject to such filing requirements for the past 90 days.
Yes [X]   No [ ]

Disclosure of delinquent filers in response to item 405 of Regulation S-B is not
contained herein, and will not be contained, to the best of registrant's
knowledge, in definitive proxy or information statements incorporated by
reference in Part III of this Form 10-KSB or any amendment to this Form
10-KSB. [X]

Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act).  Yes [ ]   No [X]

State issuer's revenue for its most recent fiscal year:  None.

A market value of the voting stock held by non-affiliates can not be determined
because the registrant does not have an active trading market.

As of March 15, 2008 the registrant had 34,940,437 shares of common stock
outstanding.

Documents incorporated by reference:  None.

Transitional Small Business Disclosure Format:  Yes [ ]   No [X]

<PAGE>

                               TABLE OF CONTENTS

                                     PART I
                                                                           Page
Item 1.  Description of Business                                              2
Item 2.  Description of Property                                              6
Item 3.  Legal Proceedings                                                    6
Item 4.  Submission of Matters to a Vote of Security Holders                  6

                                    PART II

Item 5.  Market for Common Equity and Related Stockholder Matters             7
Item 6.  Management's Discussion and Analysis or Plan of Operation            7
Item 7.  Financial Statements                                                 8
Item 8.  Changes In and Disagreements with Accountants on Accounting and
         Financial Disclosure                                                 8
Item 8A. Controls and Procedures                                              8
Item 8B. Other Information                                                    8

                                   PART III

Item 9.  Directors, Executive Officers, Promoters and Control Persons,
         Compliance with Section 16(a) of the Exchange Act                    9
Item 10. Executive Compensation                                              10
Item 11. Security Ownership of Certain Beneficial Owners and Management
         and Related Stockholder Matters                                     10
Item 12. Certain Relationships and Related Transactions, and Director
         Independence                                                        12
Item 13. Exhibits                                                            12
Item 14. Principal Accountant Fees and Services                              12
Signatures                                                                   13


In this registration statement references to "Ozone Man," "we," "us," and "our"
refer to The Ozone Man, Inc.


               SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

The Securities and Exchange Commission ("SEC") encourages companies to disclose
forward-looking information so that investors can better understand future
prospects and make informed investment decisions.  This report contains these
types of statements.  Words such as "may," "will," "expect," "believe,"
"anticipate," "estimate," "project," or "continue" or comparable terminology
used in connection with any discussion of future operating results or financial
performance identify forward-looking statements.  You are cautioned not to Place
undue reliance on the forward-looking statements, which speak only as of the
date of this report.  All forward-looking statements reflect our present
expectation of future events and are subject to a number of important factors
and uncertainties that could cause actual results to differ materially from
those described in the forward-looking statements.

                                       1

<PAGE>

                                     PART I

Item 1. Description of Business

History

The Company was incorporated in Florida in 1979 under the name Dauphin, Inc. and
its original business was the marketing of cosmetics and hair care products.  In
March 1981 the Company completed an initial public offering and continued in
business into 1982 at which time it ceased operations.  In July 1994 the Company
completed a reverse merger with RPS Enterprises, Inc. ("RPS") pursuant to which
RPS became a wholly owned subsidiary, conducting a New York based limousine
company.  RPS ceased operations in early 1996 and the Company has conducted no
business since that time.  In August 2002, certain investors purchased the
majority of prior management's stock and in October 2002 sold back the operating
subsidiary to prior management and changed the Company name to RPS Group.  In
October 2007 RPS Group and its controlling shareholders entered into a
definitive Agreement and Plan of Reorganization whereby RPS Group acquired 100%
of the issued and outstanding common shares of The Ozone Man, Inc., a Nevada
Corporation (a Development Stage Company) ("Ozone Nevada") in exchange for the
issuance of 34,250,000 shares of RPS Group common stock and $50,000 cash
consideration.  Although RPS Group is the legal acquirer, for accounting
purposes Ozone Nevada is the surviving entity and, accordingly, the transaction
will be accounted for as a reverse acquisition which is in substance a
recapitalization of Ozone Nevada.

Business

The Company is engaged in home inspection, air quality testing and ozone indoor
cleaning together with ultraviolet germicidal maintenance and intends to
franchise and/or license these operations.

Products

Ozone is a pale blue, unstable gas molecule because it consists of 3 atoms,
whereas oxygen is a molecule consisting of 2 oxygen atoms.  This ozone molecule
is so unstable that it quickly breaks away from the other oxygen atoms.  These
lone oxygen atoms go in search of other atoms to re-form into oxygen.  If it
finds a carbon or sulfur molecule, it will break into that molecule destroying
it in the process.  Free oxygen atoms are highly reactive and they will oxidize
or inactivate almost anything including most viruses, bacteria, and organic and
inorganic compounds they contact, making ozone an enormously powerful
disinfectant and oxidizer.  Since most indoor air pollutants are carbon and
sulfur based, ozone will attack them, leaving only oxygen in their place.  Ozone
is a much stronger oxidizer than common disinfectants such as chlorine and
hypochlorite.  The usage of chlorine in many countries has been decreased
significantly due to the possible formation of carcinogenic by-products during
the disinfections process.  In contrast, ozone disinfections using the Company's
methodology does not produce any harmful residues, all carcasses are vacuumed
with HEPA vacuum, and all the residual ozone will be converted back to oxygen in
a short time.  Ozone produced using ultra-violet is considered an
environmentally friendly disinfectant.

Ozone is not to be confused with smog, which is commonly referred to as ozone.
Low level or surface ozone (smog) is formed when oxygen combines with volatile
organic compounds (nitrogen oxides from motor vehicles and power plant
emissions, solvents, etc.), which then chemically react in the presence of
sunlight and warmth.

Ozone is produced by lighting (that "fresh air smell" after a storm) and by
ultra-violet radiation.  Ozone gas purifies the air and environment naturally,
leaving oxygen in its place.

                                       2

<PAGE>

Our proprietary UV ozone generators produce nothing but ozone.  Most other
manufacturers of ozone equipment produce nitrous oxides, which when mixed with
moisture become nitric acid, which is dangerous.  The EPA has determined that
the highest level of safe ozone is 0.05 ppm.  Our high-powered generators
produce ozone at lethal levels exceeding 20.0 ppm.  This is why people, pets,
or plants cannot remain in the property during our treatments that average 4
hours in length.

Market

Recognition of indoor pollution is growing.  The EPA has indicated that at least
50% of all illnesses are caused or aggravated by indoor air pollution and made
it among its top five most urgent environmental issues.  According to the EPA,
this problem creates over $1 billion in direct healthcare costs, and as much as
$60 billion in annually lost productivity.  Further, the EPA states that today's
homes contain an estimated 1,500 hazardous compounds from approximately 3,000
man-made products.  Even low levels of pollutants emitted by these products can
affect human health over a period of months or years.  Ozone can also be used to
kill, inactivate, reduce, and in some cases eliminate most of the broad causes
of indoor pollution such as: allergens, dust mites, bacteria, residue from
pesticides, construction by-products, inactivates viruses, and smoking and
cooking odors.

Accordingly, we seek to position The Ozone Man, Inc. as a leader in the
residential and commercial indoor inspection, air testing and ozone deep
cleaning treatment.  We have developed and acquired a platform of ozone
generator products, services and technologies.

We believe The Ozone Man, Inc.'s products will help real estate brokers who had
lost a sale because of bad odor in the house, had a listing they knew would be
hard to sell because of odors, and had buyers with allergies who requested
testing for the indoor air quality.  The Ozone Man, Inc. can quickly and
effectively eliminate those odors without risk using an all-natural and chemical
free solution.

The Ozone Man, Inc. methodology is a process that purifies the air in a home or
building.  This process eliminates pet odors, cooking smells, smoking odors, and
chemical smells (such as paint, glue, new carpets, etc.).  It will also
eliminate most germs, viruses, bacteria, mildew, and mold, in a multi-process
one-day event.

Services

We do indoor inspections and indoor air testing which is certified by the Indoor
Environment Standards Organization (IESO) and Environmental Solutions
Association (ESA).  This translates to professional sampling capabilities as
well as indoor contamination inspection certifications.  We inspect for any type
of indoor environmental problems.

On February 23, 2008 we purchased from S.C.O. Medallion Healthy Homes LTD all
intellectual property for the Medallion methodology system and all marketing
materials, studies and information required to operate the system including
patents, trademarks, extensions, applications, copyrights, equipment and
technology that specifically relate to the products and services of the
business.  This provides us with the ozone treatment system that is the core of
our business model.

We are a solution provider for these indoor pollution problems.  Our ozone deep
cleaning treatment is a remedy for indoor pollution about 75-80% effective.
When extreme contamination problems exist, we may call in other professionals to
assist in the remediation process and/or refer the client to another source for
the solution.

                                       3

<PAGE>

We provide indoor pollution maintenance for all buildings.  We call our system
the "Terminator", and it involves installation of a UV germicidal system in the
air ducts or air conditioning systems.  This purifies the air before it enters
the indoor environment and insures the client of a clean fresh air supply at all
times.  If there is not a forced air or air conditioning system in the home or
building, we have freestanding UV germicidal systems.

Our ozone deep cleaning treatment involves placing The Ozone Man, Inc. UV ozone
generators throughout an uninhabited home or building.  Depending on the type of
contamination, the generators are left running for 4-8 hours.  This is the
essential time allotted for the ozone to oxidize all the contaminants in the
indoor environment, leaving the space odor and contaminant free.  This one step
process works on all types of odors, including smoke, pet, cooking and chemical
odors and kills and or eliminates all allergens, bacteria and viruses.

Decontaminated space will remain as such, as long as you do not reintroduce the
problem.  Our inspection service will first identify the problem, and once the
source is removed/repaired, the treatment is then complete and the problem is
solved.  However, if you are a smoker and if you start smoking again in the
residence/office and/or you are a pet owner and you bring the pets back into the
residence and/or your residence building has another leak/water intrusion, the
problem will reoccur and another treatment will be required.  Once our treatment
is complete, the indoor environment is a healthy place to reside or work.

The cost per treatment depends on the size of the dwelling and the type of
contamination.  Residential dwellings range from $499 for apartments to $875 for
homes up to 2,500 sq ft.  Depending on size, vehicles, RV's and boats range
from $99 to $349.  Inspection services start at $175 and if sampling is
required, those prices are $595 with lab costs not included.  Installed UV
systems begin at $495.  Commercial jobs generally run around $.35 per sq ft.

Franchising and Licensing

We plan on bringing The Ozone Man, Inc. to the public via independent service
franchises or licenses.  Our franchisees or licensees will perform home
inspection, indoor air testing using a federally certified United States lab -
our franchisees or licensees initial revenue source.  After laboratory results
are obtained, the technician will evaluate results to determine the
appropriateness of our ozone deep cleaning treatment.  If conditions are
appropriate, our franchisees will use our ultraviolet generators to perform
ozone deep cleaning treatment - a second revenue source.  During this treatment
ozone will be substituted for indoor oxygen at the location. Prior to the
treatment all persons, plants, and pets will be removed. The level of ozone to
be obtained will be at least 10 ppm.  At these levels, ozone deep cleaning
treatment has been shown to reduce, inactivate, or in some cases eliminate
allergens, VOC's, bacteria/viruses, cleaning and pesticide residue, mold,
cooking & smoking odors and dust mites.

After the removal of ozone, which has a half-life of 20 minutes - 2 hours, the
room will be tested.  When ozone levels are below EPA standards individuals may
reenter the property.  We plan to develop an Ozone Man accessory line to help
with maintenance of the indoor air quality environment.  We believe
opportunities will develop for ongoing ozone deep cleaner treatment as a
maintenance service - providing our franchisees or licensees with a third source
of revenue.  These may be in the form of ongoing maintenance contracts thereby
generating recurring revenue.

There are multiple trends that we believe Ozone Man can capitalize to make our
franchises or licensees extremely desirable.  We are offering an environmentally
friendly alternative to harsh chemicals.  In addition to the detriment that
occurs to the environment when these chemicals are disposed of, their use within
homes is a source of indoor pollution.

                                       4

<PAGE>

We believe our services provide tangible health benefits for persons living and
working in areas plagued by high levels of indoor pollution.  These benefits
should be most recognizable for individuals who are highly allergic and with
faltering health.  Accordingly, we believe that our services will be highly
sought after by much of America's aging population.  Moreover, products
perceived to provide health benefits are less susceptible to economic cycles.
By providing health related services to America's aging population we are
focused on two critical trends in the nation. Across many areas of the country,
real estate prices are severely declining and inventories of real estate are
growing.  This decline is also related to job cutbacks in many real estate,
mortgage, and related industries.  Many experts are even forecasting an overall
deterioration for the domestic economy.  We believe that Ozone Man franchises
are ideally suited for launch under these conditions.

Brokers can utilize ozone deep cleaner treatment to assist them in speeding
sales of slow-moving properties.  Many of the areas most severely affected by
the downturn in the real estate market are inhabited by aging populations and
have substantial amounts of new construction.  As mentioned earlier, many new
construction materials contribute to indoor air quality problems - providing an
exceptional opportunity for us.

Many individuals employed as mortgage and real estate brokers have developed
sales skills and may seek alternate employment given the current market
conditions in these industries.  We believe an investment in an Ozone Man
franchise or licenses can be well suited for such individuals.  Over the past
5 or 10 years, many individuals generated tremendous capital in these
industries.  Additionally, as many of these industries are largely based on
commissions, these individuals have developed an entrepreneurial spirit.  With
enough capital to start launch their businesses, sales skills to effectively
market their product, and an entrepreneurial mindset, these individuals should
be able to recognize tremendous value, and invest in an Ozone Man franchise.
With Ozone Man maintenance programs, our franchises or licenses will have the
added benefit of contractual recurring revenue, a distinguishing feature from
many other franchise opportunities, and a revenue source for our company that
typically merits higher valuations from Wall Street.

With the winding down of America's military operations in Iraq many former
service persons are returning with knowledge of proper handling procedures for
hazardous materials.  The training that these individuals received on handling
biologically and chemically active substances would serve as an excellent
background for the operation of an Ozone Man franchise or license.

Real Estate Agents are our first line of potential franchisees.  With the
national slowdown in the real estate markets, we feel that many real estate
agents are seeking to provide ancillary services where they can use their real
estate skills and contacts to sell a home treatment service, such as ozone deep
cleaning treatment, to many of their old and potential new clients as well as
other associates in the real estate industry.  Another key selling point is the
testing and methodology that Ozone Man uses is a way of protecting the real
estate agent against potential litigation for non-disclosure of mold and other
related issues.  The real estate agent is seen as having a built in client and
referral base along with a demonstrated ability to pass tests, which requires
industry comprehension and understanding of rules and regulations.

Police and Fireman: Most responders are in touch and connected within the local
community and have community respect.  They possess a relationship with numerous
businesses, restaurants, apartment and homeowners.  They have had training in
hazardous materials, and understand the importance of healthy home environments
and safety.  Most are physically fit and some may have a desire to operate a
secondary business that fits into their schedule, which typically consist of two
days on followed by two days off.  They may use their trained skills in a
different application without the personal risks inherit of their profession.

                                       5

<PAGE>

One of last groups of prospective franchisees will be troops coming home from
the Middle East.  There will be over 200,000 troops coming back to the work
place in the near future. Many have lost jobs as a result of their military
duties oversees and would be seeking opportunities that can provide for their
family's welfare.  Most are physically fit and likely to be trained in toxic
chemical use and hazardous materials care, therefore they would be suited to
address and safety issues surround the use of ozone for treating indoor air
pollution.  Additionally, we will assist each soldier in obtaining federal
funding from federally supported sources available only to veterans, for them
to acquire franchisees.

We have recently aligned with a number of manufacturers of air testing kits and
ozone generation equipment manufacturers.  We currently do not consider any one
supplier to be critical to our operations.  Our management team is currently
seeking to develop strategic alliances with governmental relations specialists.
We believe these efforts can result in home purchasers being given an option to
have the indoor air quality of their future home tested prior to the closing of
a transaction.  We are actively pursuing the development of strategic alliances
that we feel are advantageous to the Company.

Competitors & Future Competition

Although we are unaware of any direct public competition, we believe that we
will be faced with competition from an array of household cleansers, pesticides,
and remediation companies (among others) for our services.  Many retailers
market a variety of air purifiers.  The ozone generation business may lead to
multiple competitors and competition.

Employees

We currently have 3 employees, 1 of which is full time.


Item 2. Description of Property

The Company leases 400 sq ft at 9454 Wilshire Blvd., Beverly Hills, CA 90212 at
$30,000 annually in a professional office building.  We believe the current
facilities are adequate for the immediate future.


Item 3. Legal Proceedings

We are not a party to any proceedings or threatened proceedings as of the date
of this filing.


Item 4. Submission of Matters to a Vote of Security Holders

We have not submitted a matter to a vote of our shareholders during the fourth
quarter of the 2007 fiscal year.

                                       6

<PAGE>

                                    PART II

Item 5. Market Price For Common Equity and Related Stockholder Matters

Market Information

Our common stock is not listed on an established trading market.

Holders and Dividends

As of March 15, 2008 we had 702 shareholders of record holding 34,940,437 common
shares.  This number does not include the common stock recently sold in a
private placement as those shares have been subscribed for, but are not yet
issued and outstanding.

We have not paid cash or stock dividends on our common stock.  We have no
present plan to pay any dividends, but intend to reinvest our earnings, if any.

Recent Sales of Unregistered Securities

In the first quarter of 2008, we sold 1,675,000 shares of common stock for
total consideration of $335,000 pursuant to Regulation D Rule 505.

Issuer Purchase of Securities

None.


Item 6.  Management's Discussion and Analysis or Plan of Operation

Results of Operations for the initial period ended December 31, 2007: Ozone Man
(FL) has had no business operations since 2002. Ozone Man (NV), acquired in
October 2007 was incorporated in September 2007 and is a development stage
company that has not yet generated revenues from planned operations. We have
only incurred expenses such as professional and regulatory fees and merger
expenses.  Those expenses totaled $47,304 for the initial period ended December
31, 2007. As such we also recorded a net loss of $32,860 for the initial period
ended December 31, 2007.

Liquidity and Capital Resources: Our business plan is to engage in the home
inspection, air quality testing and ozone indoor cleaning business. We also
intend to license or franchise these operations. We have very limited sources
of capital as we have not yet generated revenues from operations.

We are currently engaged in a private placement pursuant to Regulation D, Rule
505, and have raised $335,000 from the sale of 1,675,000 shares of common stock
in the first quarter of 2008. If the entire private placement is sold, we may
raise an additional $665,000. If we are able to raise the additional funds, we
believe it should be sufficient to implement our business plan through the end
of 2008. There is no assurance additional private placement funds will actually
be raised and the failure to do so will make it more difficult to implement our
business plan.

Our independent accounting firm has expressed substantial doubt that we can
continue as a going concern unless, among other things, we obtain financing.
At December 31, 2007, we had $3,095 in cash and liabilities of $27,413.

                                       7

<PAGE>

Plan of Operation

We have purchased all intellectual property related to the ozone cleaning
methodology and are finalizing an agreement to acquire air quality testing
equipment. Once both pieces are in place we intend to penetrate both the
residential and commercial markets with our services and products. We have
developed a comprehensive marketing plan and advertising materials and intend to
provide these materials to and train real estate agents, first responders and
others in the use of both the ozone cleaning system and air testing equipment.

Off-Balance Sheet Arrangements

None.


ITEM 7. FINANCIAL STATEMENTS

The required financial statements begin on page F-1 of this document.


ITEM 8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
        FINANCIAL DISCLOSURE

During the two most recent fiscal years we have not had a change in, or
disagreement with, our independent registered public accounting firm.


Item 8A.  Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that
information required to be disclosed in our filings under the Exchange Act is
recorded, processed, summarized and reported within the periods specified in the
rules and forms of the SEC.  This information is accumulated to allow timely
decisions regarding required disclosure.  Our President, who acts in the
capacities of our principal executive officer and principal financial officer,
evaluated the effectiveness of our disclosure controls and procedures as of the
end of the period covered by this report.  Based on that evaluation, he
concluded that our disclosure controls and procedures were effective.

He also determined that there were no changes made in our internal controls over
financial reporting during the fourth quarter of 2007 that have materially
affected, or are reasonably likely to materially affect our internal control
over financial reporting.


Item 8B. Other Information

See History in Item 1 above.  A change in control occurred in October 2007.
Control was acquired by Halden S. Shane, Richard L. Johnson, Juliann Gold and
Roar Investment, LLC pursuant to an Agreement and Plan of Reorganization dated
October 15, 2007.  The above named parties own 62% of the Company's outstanding
common stock.  Control was acquired from Harold Paul, David Lindner, Anthony
Kirincic and Kirlin Holding Corp., the majority shareholders of RPS Group, Inc.
Consideration paid was $50,000, comprised of $25,000 in company funds of the
Ozone Man, Inc., the acquired company, and a $25,000 promissory note.  Mr. Paul
resigned as an acting officer and director upon the closing of the transaction
on October 17, 2007.  As a result of the transaction, the Company ceased being a
shell company.  Inasmuch as the Company's stock was not trading and the Company
would not have been able to timely supply the requisite financial information,
it deferred reporting these events until the current filing.

                                       8

<PAGE>

                                    PART III

Item 9. Directors, Executive Officers, Promoters and Control Persons,
        Compliance With Section 16(A) of the Exchange Act

Our executive officers and directors, their ages and biographical information
are presented below.  Our bylaws require three directors who serve until our
next annual meeting or until each is succeeded by a qualified director.  Our
executive officers are appointed by our Board of Directors and serve at its
discretion.  There are no existing family relationships between or among any of
our executive officers or directors.

Name                   Age   Position Held                       Director Since
--------------------   ---   ---------------------------------   --------------

Halden S. Shane        63    Chief Executive Officer, Director   October 2007

Richard L. Johnson     72    Chief Operating Officer,            October 2007
                             Secretary, Director

Willie L. Brown, Jr.   73    Director                            October 2007

Halden S. Shane: Dr. Shane has been our Chairman since the Company's inception.
For the past five years he has served as President and CEO of Tiger of Tiger
Management International: a private management company that deals in business
management of private and public companies.  Dr. Shane was also: Founder and
General Partner of Doctors Hospital West Covina, California. Prior to the
previous mentions, Dr. Shane practiced podiatric surgery specializing in ankle
arthroscopy.

Richard L. Johnson: Since his admission to the California State Bar Association
in 1961, Mr. Johnson has served as a business manager/attorney and consultant to
a variety of individuals and companies.  He is presently active in private
practice in Los Angeles, California.

Willie Brown, Jr.: Mr. Brown has served two terms as the Mayor of the City and
County of San Francisco (1996-2004).  Prior to his service as Mayor, Mr. Brown
served as speaker of the California State assembly from 1980 thorough 1995.  Mr.
Brown had also been a member of the state assembly since 1964 and has served on
the Boards of California State University and Calpers.

Audit Committee

We do not have an audit committee serving at this time, nor do we have an audit
committee financial expert serving on an audit committee.  Our entire board acts
as our audit committee.

Compliance with Section 16(a) of the Exchange Act

Section 16(a) of the Securities Exchange Act of 1934 requires our directors,
executive officers and persons who own more than ten percent of a registered
class of our equity securities, to file with the Securities and Exchange
Commission initial reports of ownership and reports of changes in ownership of
our common stock. Officers, directors and greater than ten-percent beneficial
owners are required by SEC regulations to furnish us with copies of all Section
16(a) reports they file.  We believe no reports were required to be filed during
the past fiscal year.

                                       9

<PAGE>

Code of Ethics

We have not yet adopted a code of ethics for our principal executive and
financial officers.  Our board of directors will revisit this issue in the
future to determine if adoption of a code of ethics is appropriate.  In the
meantime, our management intends to promote honest and ethical conduct, full
and fair disclosure in our reports to the SEC, and compliance with applicable
governmental laws and regulations.


Item 10. Executive Compensation

Executive Officer Compensation

The following discussion addresses any and all compensation awarded to, earned
by or paid to our named executive officers for the fiscal years ended December
31, 2007. We have not had a bonus, profit sharing, or deferred compensation plan
for the benefit of employees, officers or directors.

We have not paid any salaries or other compensation to officers or directors for
their service on the Board of Directors for the year ended December 31, 2007.
Further, we have not entered into an employment agreement with any officers,
directors or any other persons and no such agreements are anticipated in the
immediate future. It is intended that directors will defer any compensation
until such time as business operations provide sufficient cash flow to provide
for salaries. As of the date hereof, no person has accrued any compensation.
The Company intends to enter in an employment agreement with the Chief Executive
Officer when it has began to generate revenues and anticipates being able to
pay him a salary.

Retirement or Change of Control Arrangements

We do not offer retirement benefit plans to our executive officers, nor have we
entered into any contract, agreement, plan or arrangement, whether written or
unwritten, that provides for payments to a named executive officer at or in
connection with the resignation, retirement or other termination of a named
executive officer, or a change in control of the company or a change in the
named executive officer's responsibilities following a change in control.

Compensation of Directors

We do not have any standard arrangement for compensation of our directors for
any services provided as director; including services for committee
participation or for special assignments.


Item 11. Security Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters

Securities Under Equity Compensation Plans

We do not have any securities authorized for issuance under any equity
compensation plans.

Beneficial Ownership

The following table sets forth the beneficial ownership of our outstanding
common stock by our management and each person or group known by us to own
beneficially more than 5% of our outstanding common stock. Beneficial ownership
is determined in accordance with SEC rules and regulations, which generally

                                       10

<PAGE>

requires voting or investment power with respect to securities.  Except as
indicated by footnote, the persons named in the table below have sole voting
power and investment power with respect to all shares of common stock shown as
beneficially owned by them.  The percentage of beneficial ownership is based on
34,940,437 shares of common stock outstanding as of March 15, 2008.


                            CERTAIN BENEFICIAL OWNERS

Name and address of                   Amount and nature of         Percent
beneficial owners                     beneficial owner             of class
-------------------                   --------------------         --------

Shane Family Trust (1)                     5,000,000                14.3 %
11710 Wetherby Lane
Los Angeles, CA 90077

Richard L. Johnson                         8,000,000                22.9 %
9454 Wilshire Blvd., Penthouse
Beverly Hills, CA 90212

Willie Brown, Jr.                             -0-                    -0-
9454 Wilshire Blvd., Penthouse
Beverly Hills, CA 90212

Juliann Gold                               4,312,500                12.3 %
9903 Santa Monica Blvd
Beverly Hills, CA 90212

Roar Investment LLC                        4,312,500                12.3 %
9903 Santa Monica Blvd
Beverly Hills, CA 90212

Belinha Shane (2)                          3,000,000                 8.6 %
11710 Wetherby Lane
Los Angeles, CA 90077

Farideh Talebpour                          2,000,000                 8.6 %
1155 N. LaCienega Blvd
Los Angeles, CA 90069

Directors and Officers as a Group (3)     13,000,000                37.2 %

(1) Halden Shane is trustee of the Share Family Trust.
(2) Belinha Shane is the wife of Halden Shane.  He disclaims beneficial
    ownership of any shares held in her name.

                                       11

<PAGE>

Item 12. Certain Relationships and Related Transactions, and Director
         Independence

Transactions with Related Parties

We have not engaged in any transactions during the past fiscal year involving
our executive officers, directors, more than 5% stockholders or immediate family
members of such persons.

Director Independence

None of our directors are independent directors as defined by NASD
Rule 4200(a)(15).


Item 13. Exhibits

No.    Description
----   -----------

 2.0   Agreement and Plan of Reorganization dated October 15, 2007
10.1   Agreement with S.C.O. Medallion Healthy Homes LTD dated February 23, 2008


Item 14.  Principal Accountant Fees and Services

Accountant Fees

The following table presents the aggregate fees billed for each of the last two
fiscal years by our independent registered public accounting firm Wolinetz,
Lafazan & Company, P.C., Certified Public Accountants, in connection with the
audit of our financial statements and other professional services rendered by
that accounting firm.

                                                        2006       2007
                                                      --------   --------
Audit fees                                            $  3,500   $  8,500
Audit-related fees                                           0          0
Tax fees                                                     0          0
All other fees                                        $  3,500   $  8,500

Audit fees represent the professional services rendered for the audit of our
annual financial statements and the review of our financial statements included
in quarterly reports, along with services normally provided by the accounting
firm in connection with statutory and regulatory filings or engagements.  Audit-
related fees represent professional services rendered for assurance and related
services by the accounting firm that are reasonably related to the performance
of the audit or review of our financial statements that are not reported under
audit fees.

Tax fees represent professional services rendered by the accounting firm for tax
compliance, tax advice, and tax planning.  All other fees represent fees billed
for products and services provided by the accounting firm other than the
services reported for the other categories.

                                       12

<PAGE>

Pre-approval Policies

We do not have an audit committee currently serving and as a result our board of
directors performs the duties of an audit committee.  Our board of directors
will evaluate and approve in advance the scope and cost of the engagement of an
auditor.  We do not rely on pre-approval policies and procedures.


                                 SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned who is duly
authorized.


THE OZONE MAN, INC.

Date: April 3, 2008
By: /s/ Halden Shane
---------------------------
Halden Shane
Principal Executive Officer


In accordance with the Exchange Act, this report has been signed below by
the following persons on behalf of the registrant and in the capacities and on
the dates indicated.


Date: April 3, 2008
By: /s/ Halden Shane
---------------------------
Halden Shane
Principal Executive Officer
Principal Financial and Accounting Officer


Date: April 3, 2008
By: /s/Richard Johnson
---------------------------
Richard Johnson
Secretary and Director


Date: April 3, 2008
By: /s/Willie Brown, Jr.
---------------------------
Willie Brown, Jr.
Director


                                       13

<PAGE>


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


Board of Directors and Stockholders
The Ozone Man, Inc. (A Florida Corporation)

We have audited the accompanying consolidated balance sheet of The Ozone Man,
Inc. and Subsidiary (a Development Stage Company) ("the Company") as of December
31, 2007 and the related consolidated statements of operations, stockholders'
deficiency and cash flows for the period September 5, 2007 (inception) to
December 31, 2007.  These financial statements are the responsibility of the
Company's management.  Our responsibility is to express an opinion on these
financial statements based on our audit.

We conducted our audit in accordance with the standards of the Public Company
Accounting Oversight Board (United States).  Those standards require that we
plan and perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement.  The Company is not
required to have, nor were we engaged to perform, an audit of its internal
control over financial reporting.  Our audits included consideration of internal
control over financial reporting as a basis for designing audit procedures that
are appropriate in the circumstances, but not for the purpose of expressing an
opinion on the effectiveness of the Company's internal control over financial
reporting.  Accordingly, we express no such opinion.  Also, an audit includes
examining, on a test basis, evidence supporting the amounts and disclosures in
the financial statements, assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation.  We believe that our audit provides a
reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of The Ozone Man, Inc. and
Subsidiary at December 31, 2007, and the results of their operations and their
cash flows for the period September 5, 2007 (inception) to December 31, 2007 in
conformity with accounting principles generally accepted in the United States of
America.

The accompanying financial statements have been prepared assuming the Company
will continue as a going concern.  As discussed in Note 2 to the financial
statements, the Company has incurred an operating loss and has had no revenues
for the period September 5, 2007 (inception) to December 31, 2007 and has not
commenced planned principal operations.  In addition, at December 31, 2007 the
Company had a working capital and stockholders' deficiency  These factors raise
substantial doubt about the Company's ability to continue as a going concern.
Management's plans regarding those matters are also described in Note 2.  The
financial statements do not include any adjustments that might result from the
outcome of this uncertainty.



                                             WOLINETZ, LAFAZAN & COMPANY, P.C.



Rockville Centre, New York
March 31, 2008


                                      F-1

<PAGE>


                       THE OZONE MAN, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
                           CONSOLIDATED BALANCE SHEET
                                DECEMBER 31, 2007


                                     ASSETS

Current Assets:
   Cash                                                             $     3,095
                                                                    ------------
        Total Current Assets                                              3,095
                                                                    ------------
Total Assets                                                        $     3,095
                                                                    ============

                    LIABILITIES AND STOCKHOLDERS' DEFICIENCY

Current Liabilities:
   Accounts Payable                                                 $     6,857
   Convertible Note Payable - Related Party, Net of Discount             10,556
   Other Payables                                                        10,000
                                                                    ------------
        Total Current Liabilities                                        27,413
                                                                    ------------
        Total Liabilities                                                27,413
                                                                    ------------

Commitments and Contingencies

Stockholders' Deficiency:
   Preferred Stock, $25 par value; 1,000,000 shares
     authorized, none issued and outstanding                                  -
   Common Stock, $.01 par value; 75,000,000 shares
     authorized, 34,940,437 shares issued and outstanding               349,404
   Additional Paid-In Capital                                            29,900
   Accumulated Deficit                                                 (370,762)
   Deficit Accumulated in the Development Stage                        ( 32,860)
                                                                    ------------
        Total Stockholders' Deficiency                                 ( 24,318)
                                                                    ------------
Total Liabilities and Stockholders' Deficiency                       $    3,095
                                                                    ============

The accompanying notes are an integral part of these financial statements.

                                      F-2

<PAGE>

                       THE OZONE MAN, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
                      CONSOLIDATED STATEMENT OF OPERATIONS
        FOR THE PERIOD SEPTEMBER 5, 2007 (INCEPTION) TO DECEMBER 31, 2007


Net Revenues                                                        $         -
                                                                    ------------
Costs and Expenses:
   Professional Fees                                                     13,875
   Other General and Administrative Expenses                              8,429
   Merger Expense                                                        25,000
                                                                    ------------
        Total Costs and Expenses                                         47,304
                                                                    ------------
Loss before Other Income (Expense)                                     ( 47,304)
                                                                    ------------
Other Income (Expense):
   Financing Costs                                                     ( 10,556)
   Forgiveness of Debt                                                   25,000
                                                                    ------------
                                                                         14,444
Net Loss                                                            $  ( 32,860)
                                                                    ============
Basic and Diluted Loss Per Share                                    $  (    .00)
                                                                    ============
Weighted Average Basic and Diluted Shares Outstanding                34,935,367
                                                                    ============

The accompanying notes are an integral part of these financial statements.

                                      F-3

<PAGE>

                       THE OZONE MAN, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
               CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIENCY
        FOR THE PERIOD SEPTEMBER 5, 2007 (INCEPTION) TO DECEMBER 31, 2007

<TABLE>
<CAPTION>
                                                                                                          Deficit
                                                                                                          Accumulated
                                   Preferred Stock        Common Stock         Additional                 in the
                                   ---------------   -----------------------   Paid-In      Accumulated   Development
                                   Shares  Amount    Shares        Amount      Capital      Deficit       Stage         Total
                                   ------  -------   ------------  ---------   ----------   -----------   -----------   ----------
<S>                                <C>     <C>       <C>           <C>         <C>          <C>           <C>           <C>
Balance - September 5, 2007            -   $    -              -   $      -    $       -    $        -    $        -    $       -

Sale of Common Stock to
  Founders of Ozone - NV               -       -      30,000,000      3,000       27,000             -             -       30,000

Issuance of Common Stock in
  Connection with Reverse              -       -      34,250,000    342,500     (342,500)            -             -            -
  Acquisition

Effect of Recapitalization             -       -         680,437      6,804      312,500      (370,762)            -     ( 51,458)
                                                     (30,000,000)  (  3,000)       3,000             -             -            -
Issuance of Common stock for
  Services                             -       -          10,000        100        4,900             -             -        5,000

Beneficial Conversion Feature          -       -               -          -       25,000             -             -       25,000

Net Loss for the Period
  September 5, 2007 (Inception)
  to December 31, 2007                 -       -               -          -            -             -       (32,860)    ( 32,860)
                                   ------  -------   ------------  ---------   ----------   -----------   -----------   ----------
Balance - December 31, 2007            -   $   -      34,940,437   $349,404    $  29,900    $ (370,762)   $  (32,860)   $( 24,318)
                                   ======  =======   ============  =========   ==========   ===========   ===========   ==========

</TABLE>

The accompanying notes are an integral part of these financial statements.

                                      F-4

<PAGE>

                       THE OZONE MAN, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
                      CONSOLIDATED STATEMENT OF CASH FLOWS
        FOR THE PERIOD SEPTEMBER 5, 2007 (INCEPTION) TO DECEMBER 31, 2007


Cash Flows from Operating Activities:
   Net Loss                                                         $  ( 32,860)
  Common Stock Issued for Services                                        5,000
  Debt Forgiveness                                                     ( 25,000)
  Amortization of Debt Discount                                          10,556
   Adjustments to Reconcile Net Loss to Net Cash Used
    in Operating Activities:
   Changes in Assets and Liabilities:
     Increase in Accounts Payable                                         5,339
                                                                    ------------
        Net Cash Used in Operating Activities                          ( 36,905)
                                                                    ------------
Cash Flows from Investing Activities:                                         -
                                                                    ------------
Cash Flows from Financing Activities:
   Proceeds from Sale of Common Stock                                    30,000
   Proceeds of Other Payables                                            10,000
                                                                    ------------
        Net Cash Provided by Financing Activities                        40,000
                                                                    ------------
Increase in Cash                                                          3,095

Cash - Beginning of Period                                                    -
                                                                    ------------
Cash - End of Period                                                $     3,095
                                                                    ============

Supplemental Disclosures of Cash Flow Information:

   Interest Paid                                                    $         -
                                                                    ============
   Income Taxes Paid                                                $         -
                                                                    ============

Supplemental Disclosures of Cash Flow Information:
  Non-Cash Financing Activities:
     Issuance of Note Payable - Related Party as Payment of
       Accounts Payable                                             $     25,000
                                                                    ============
     Issuance of 34,250,000 shares of Common Stock in
       Connection with Reverse Acquisition (Recapitalization)       $    342,500
                                                                    ============
     Discount on Convertible Debt                                   $     25,000
                                                                    ============

The accompanying notes are an integral part of these financial statements.

                                      F-5

<PAGE>

                       THE OZONE MAN, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 - Summary of Significant Accounting Policies

         Organization

         The Ozone Man, Inc. ("Ozone-FL") was originally incorporated in the
state of Florida in 1979 as Dauphin, Inc. ("Dauphin").  On June 27, 1994
Dauphin, through an exchange agreement, acquired 100% of the outstanding common
stock of RPS Executive Limousines, Ltd., a privately held New York Corporation
("RPS Limo").  On July 19, 1994, Dauphin changed its name to RPS Enterprises,
Ltd. and effected a one-for-three reverse split of its common stock.  In
addition, the Certificate of Incorporation was amended  to (a) increase the
number of authorized common shares, $.01 par value, from 10,000,000 shares to
20,000,000 shares and (b) to create 1,000,000 shares of a new class of
cumulative convertible $25.00 preferred stock, with semi-annual dividends of
$2.00 per share.  The acquisition resulted in the RPS Limo shareholder emerging
with a larger portion of voting rights of the combined company.  Accordingly,
the transaction was treated for accounting purposes as a reverse acquisition.

         In August 2002, certain investors purchased the majority of prior
management's stock and changed the name from RPS Enterprises Ltd. to RPS Group,
Inc. ("RPS Group").  In October 2002 RPS Group sold back the operating
subsidiary (RPS Limo) to prior management.  RPS Group has been a shell company
with no significant assets or operations since 2002.

         On September 5, 2007, The Ozone Man, Inc. was incorporated in the State
of Nevada ("Ozone-NV").  On October 15, 2007, RPS Group, Inc filed with the
State of Florida, an amendment to its Articles of Incorporation changing its
name to The Ozone Man, Inc. ("Ozone-FL") and increasing it's authorized common
shares from 20,000,000 to 75,000,000 shares. In addition Ozone-FL executed a
1:20 stock split.

         On October 17, 2007, pursuant to a Definitive Agreement and Plan of
Reorganization, Ozone-FL acquired 100% of the issued and outstanding common
shares of Ozone-NV in exchange for 34,250,000 shares of Ozone-FL's common stock
(as amended) and $25,000 cash consideration. The combination of the two
companies is recorded as a recapitalization of Ozone-NV pursuant to which
Ozone-NV is treated as the continuing entity although Ozone-FL is the legal
acquirer. Accordingly, the Company's historical financial statements are those
of Ozone-NV. Ozone-FL and Ozone-NV are hereafter collectively referred to as
"the Company".

         Description of Company

         The Company is engaged in home inspection, air quality testing and
ozone indoor cleaning and intends to franchise and/or license these operations.

         The Company has not yet generated revenues from planned principal
operations and is considered a development stage company as defined in Statement
of Financial Accounting Standards ("SFAS") No. 7.

         Consolidation

         The accompanying consolidated financial statements included the
accounts of The Ozone Man, Inc. (a Florida Corporation) (Parent) and its wholly
owned subsidiary The Ozone Man, Inc. (a Nevada Corporation). All significant
intercompany accounts and transactions have been eliminated in consolidation.

         Cash and Cash Equivalents

         The Company considers all highly-liquid investments purchased with a
maturity of three months or less to be cash equivalents.

                                       F-6

<PAGE>

                       THE OZONE MAN, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 - Summary of Significant Accounting Policies (Continued)

         Revenue Recognition

         For revenue from product sales, the Company will recognize revenue in
accordance with Staff Accounting Bulletin No. 104, "Revenue Recognition" (SAB
No. 104), which superseded Staff Accounting Bulletin No. 101, "Revenue
Recognition in Financial Statements" (SAB No. 101).  SAB No. 104 requires that
four basic criteria must be met before revenue can be recognized: (1) persuasive
evidence of an arrangement exists; (2) delivery has occurred; (3) the selling
price is fixed and determinable; and (4) collectibility is reasonably assured.
Determination of criteria (3) and (4) are based on management's judgment
regarding the fixed nature of the selling prices of the products delivered and
the collectibility of those amounts.  Provisions for discounts and rebates to
customers, estimated returns and allowance, and other adjustments will be
provided for in the same period the related sales are recorded.

         Advertising Costs

         Advertising costs will be charged to operations when incurred.  The
Company did not incur any advertising costs during the period September 5, 2007
(inception) to December 31, 2007.

         Income Taxes

         The Company accounts for income taxes using the asset and liability
method described in SFAS No. 109, "Accounting For Income Taxes", the objective
of which is to establish deferred tax assets and liabilities for the temporary
differences between the financial reporting and the tax bases of the Company's
assets and liabilities at enacted tax rates expected to be in effect when such
amounts are realized or settled.  A valuation allowance related to deferred tax
assets is recorded when it is more likely than not that some portion or all of
the deferred tax assets will not be realized.

         Loss Per Share

         The computation of loss per share is based on the weighted average
number of common shares outstanding during the period presented.  Diluted loss
per common share is the same as basic loss per common share as there are no
potentially dilutive securities outstanding (options and warrants).  The common
stock issued and outstanding has been included from September 5, 2007
(inception) with respect to the effect of the recapitalization.

         Accounting Estimates

         The preparation of financial statements in conformity with generally
accepted accounting principles in the United States of America requires
management to make estimates and assumptions that affect the reported amounts
of assets and liabilities, the disclosures of contingent assets and liabilities
at the date of the financial statements, and the reported amount of revenues and
expenses during the reported period.  Actual results could differ from
those estimates.

         Fair Value of Financial Instruments

         The carrying value of cash and accounts payable approximates fair value
because of the immediate or short-term maturity of these financial instruments.

                                      F-7

<PAGE>

                       THE OZONE MAN, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 - Summary of Significant Accounting Policies (Continued)

         Research and Development

         Research and development costs will be charged to operations as
incurred.  There were no research and development costs during the period
September 5, 2007 (inception) to December 31, 2007.

         Stock Based Compensation

         The Company has adopted SFAS 123(R), "Share-Based Payment," which
supersedes APB Opinion No. 25, "Accounting for Stock Issued to Employees" and
eliminates the intrinsic value method that was provided in SFAS 123, "Accounting
for Stock-Based Compensation" for accounting of stock-based compensation to
employees.  The Company made no employee stock-based compensation grants during
the period September 5, 2007 (inception) to December 31, 2007.

         Recently-Enacted Accounting Standards

         In June 2006, the FASB issued "Accounting for Uncertain Tax Positions -
an Interpretation of FASB Statement No. 109", ("FIN No. 48"), which prescribes a
recognition and measurement model for uncertain tax positions taken or expected
to be taken in the Company's tax returns. FIN No. 48 provides guidance on
recognition, classification, presentation, and disclosure of unrecognized tax
benefits. Fin No. 48 is effective for fiscal years beginning after December 15,
2006, The adoption of this statement  have no material  impact on the Company's
financial position, results of operations or cash flows.

         In September 2006, the FASB issued SFAS No. 157, "Fair Value
Measurements", which defines fair value, establishes a framework for measuring
fair value, and expands fair value disclosures. The standard does not require
any new fair value measurements. This standard is effective for fiscal years
beginning after November 15, 2007. The adoption of this new standard is not
expected to have a material effect on the Company's financial position, results
of operations or cash flows.

         In December 2006, the FASB issued FSP EITF 00-19-2, "Accounting for
Registration Payment Arrangements" ("FSP 00-19-2"), which addresses accounting
for registration payment arrangements. FSP 00-19-2 specifies that the contingent
obligation to make future payments or otherwise transfer consideration under a
registration payment arrangement, whether issued as a separate agreement or
included as a provision of a financial instrument or other agreement, should be
separately recognized and measured in accordance with SFAS No. 5, "Accounting
for Contingencies". FSP 00-19-2 further clarifies that a financial instrument
subject to a registration payment arrangement should be accounted for in
accordance with other applicable generally accepted accounting principles
without regard to the contingent obligation to transfer consideration pursuant
to the registration payment arrangement. For registration payment arrangements
and financial instruments subject to those arrangements that were entered into
prior to the issuance of EITF 00-19-2, this guidance shall be effective for
financial statements issued for fiscal years beginning after December 15, 2006
and interim periods within those fiscal years. The Company does not expect the
adoption of this standard will have a material impact on its financial position,
results of operations or cash flows.

                                      F-8

<PAGE>

                       THE OZONE MAN, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 - Summary of Significant Accounting Policies (Continued)

         Recently-Enacted Accounting Standards(Continued)

         In June 2007, the FASB ratified the consensus in EITF Issue No. 07-3,
"Accounting for Nonrefundable Advance Payments for Goods or Services to be Used
in Future Research and Development Activities"  (EITF 07-3), which requires that
nonrefundable advance payments for goods or services that will be used or
rendered for future research and development (R&D) activities be deferred and
amortized over the period that the goods are delivered or the related services
are performed, subject to an assessment of recoverability.  EITF 07-3 will be
effective for fiscal years beginning after December 15, 2007.  The Company does
not expect that the adoption of EITF 07-3 will have a material impact on its
financial position, results of operations or cash flows.

         In December 2007, the FASB issued SFAS No. 141(R),"Business
Combinations" ("SFAS No. 141(R)"), which establishes principles and requirements
for how an acquirer recognizes and measures in its financial statements the
identifiable assets acquired, the liabilities assumed, and any noncontrolling
interest in an acquiree, including the recognition and measurement of goodwill
acquired in a business combination. SFAS No. 141(R) is effective as of the
beginning of the first fiscal year beginning on or after December 15, 2008.
Earlier adoption is prohibited and the Company is currently evaluating the
effect, if any, that the adoption will have on its financial position, results
of operations or cash flows.


NOTE 2 - Going Concern

         The Company had no revenues and incurred a net loss of $32,860 during
the period September 5, 2007 (inception) to December 31, 2007.  In addition, the
Company had a working capital deficit of $24,318 at December 31, 2007.  These
factors raise substantial doubt about the Company's ability to continue as a
going concern.

         There can be no assurance that sufficient funds required during the
next year or thereafter will be generated from operations or that funds will be
available from external sources such as debt or equity financings or other
potential sources.  The lack of additional capital resulting from the inability
to generate cash flow from operations or to raise capital from external sources
would force the Company to substantially curtail or cease operations and would,
therefore, have a material adverse effect on its business.  Furthermore, there
can be no assurance that any such required funds, if available, will be
available on attractive terms or that they will not have a significant dilutive
effect on the Company's existing stockholders.

         The Company's existence is dependent on management's ability to develop
profitable operations and resolve its liquidity problems.  In October 2007 RPS
Group and Ozone Nevada effected a reverse acquisition with Ozone Nevada being
the surviving entity for accounting purposes.  Management is attempting to
attain profitable operations for Ozone Nevada, however, there is no assurance
that the Company will achieve such profitable operations.

         The Company is also attempting to address its lack of liquidity by
raising additional funds, either in the form of debt or equity or some
combination thereof.  There can be no assurances that the Company will be able
to continue to raise the additional funds it requires.

         The accompanying financial statements do not include any adjustments
related to the recoverability or classification of asset-carrying amounts or the
amounts and classification of liabilities that may result should the Company be
unable to continue as a going concern.

                                      F-9

<PAGE>

                       THE OZONE MAN, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 3 - Convertible Note Payable - Related Party

         Convertible note payable consists of the following:

              Convertible note payable to related party,
	       net of unamortized discount of $14,444       $ 10,556
                                                            ========

         On October 17, 2007 a convertible promissory note in the amount of
$25,000 was issued to one individual who is a stockholder, legal counsel and
former officer of Ozone-FL as payment of accounts payable owed by the Company to
him for legal services.  The note is non-interest bearing and convertible into
2,000,000 shares of the Company's common stock at the Holder's option provided
the Maker is not in default and is due April 14, 2008.

         In connection with the convertible debt, the Company recorded a
deferred debt discount in the amount of $25,000 to reflect the beneficial
conversion feature of the convertible debt.  The beneficial conversion feature
was recorded pursuant to Emerging Issues Task Force ("EITF") 00-27: "Application
of EITF No. 98-5, Accounting for Convertible Securities with Beneficial
Conversion Features or Contingently Adjustable Conversion Ratios, to Certain
Convertible Instruments". In accordance with EITF 00-27, the Company evaluated
the value of the beneficial conversion feature and recorded the amount of
$25,000 as a reduction to the carrying amount of the convertible debt and as an
addition to paid-in capital.

         The Company is amortizing the discount over the term of the debt.
Amortization of the debt discount for the September 2, 2007 (inception) to
December 31, 2007 amounted to $10,556, and is reported as financing costs.

NOTE 4 - Common Stock

         In September 2007 Ozone-NV issued 30,000,000 shares of common stock for
$30,000 to the three founders of Ozone-NV.

         On October 15, 2007 Ozone-FL amended its Articles of Incorporation
increasing the authorized shares from 20,000,000 shares to 75,000,000 shares.
The par value remained $.01 per share.  On October 17, 2007 Ozone-FL implemented
a 1:20 reverse stock split affecting the pre-reorganization shareholders.  All
share and pre-share data have been retroactively adjusted to reflect these
recapitalizations.

         On October 17, 2007, pursuant to the aforementioned Definitive
Agreement and Plan of Reorganization the founders of Ozone-NV exchanged 100% of
their outstanding shares of Ozone-NV in return for 34,250,000 shares of
Ozone-FL's common stock (see Note 1).

         On November 1, 2007, the Company issued 10,000 shares of common stock
for the payment of professional fees in the amount of $5,000.


NOTE 5 - Preferred Stock

         The Company's Board of Directors may, without further action by the
Company's stockholders, from time to time, direct the issuance of any authorized
but unissued or unreserved shares of preferred stock in series and at the time
of issuance, determine the rights, preferences and limitations of each series.
The holders of preferred stock may be entitled to receive a preference payment
in the event of any liquidation, dissolution or winding-up of the Company before
any payment is made to the holders of the common stock.  Furthermore, the board
of directors could issue preferred stock with voting and other rights that could
adversely affect the voting power of the holders of the common stock.

                                      F-10

<PAGE>

                       THE OZONE MAN, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 6 - Income Taxes

         At December 31, 2007, the Company had available a net-operating loss
carry-forward for Federal tax purposes of approximately $22,000, which may be
applied against future taxable income, if any, through 2027.  Certain
significant changes in ownership of the Company may restrict the future
utilization of these tax loss carry-forwards.

         At December 31, 2007, the Company has a deferred tax asset of
approximately $7,000 representing the benefit of its net operating loss carry-
forwards.  The Company has not recognized the tax benefit because realization of
the tax benefit is uncertain and thus a valuation allowance has been fully
provided against the deferred tax asset.  The difference between the Federal
Statutory Rate of 34% and the Company's effective tax rate of 0% is due to an
increase in the valuation allowance of approximately $7,000.


NOTE 7 - Forgiveness of Debt

         In October 2007 a stockholder and former legal counsel and officer of
Ozone-FL waived payment of the Company's accounts payable to him for past due
legal services performed in the amount of $25,000.  Accordingly, the Company
recorded debt forgiveness income in the amount of $25,000.


NOTE 8 - Subsequent Events

         During the quarter ended March 31, 2008 the Company sold 1,675,000
shares of common stock in a private offering for gross proceeds of $335,000.

         Purchase of Intellectual Property

         On February 23, 2008 the Company purchased from S.C.O. Medallion
Healthy Homes LTD all intellectual property for the Medallion methodology system
and all marketing materials, studies and information required to operate the
system including patents, trademarks, extensions, applications, copyrights,
equipment and technology that specifically relate to the products and services
of the business for $60,000.

                                      F-11

</TEXT>
</DOCUMENT>
